292 related articles for article (PubMed ID: 23107442)
21. The relationship between staging of hepatic fibrosis and the levels of serum biochemistry.
Xu GG; Luo CY; Wu SM; Wang CL
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):246-8. PubMed ID: 14612277
[TBL] [Abstract][Full Text] [Related]
22. ROC curves in evaluation of serum fibrosis indices for hepatic fibrosis.
Zheng M; Cai WM; Weng HL; Liu RH
World J Gastroenterol; 2002 Dec; 8(6):1073-6. PubMed ID: 12439928
[TBL] [Abstract][Full Text] [Related]
23. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
Lieber CS; Weiss DG; Paronetto F;
Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
[TBL] [Abstract][Full Text] [Related]
24. [The relationship between TGFbeta1 and TIMP-1 and its effects on the diagnosis of hepatic fibrosis].
Zhang LF; Tian XX; Wang CF
Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):258-60. PubMed ID: 17456311
[TBL] [Abstract][Full Text] [Related]
25. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
Zaman A; Rosen HR; Ingram K; Corless CL; Oh E; Smith K
Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
[TBL] [Abstract][Full Text] [Related]
26. [The relationship between the levels of serum fibrosis marks and morphometric quantitative measurement of hepatic histological fibrosis].
Xie S; Yao J; Zheng S; Yao C; Zheng R
Zhonghua Gan Zang Bing Za Zhi; 2000 Aug; 8(4):203-5. PubMed ID: 10951617
[TBL] [Abstract][Full Text] [Related]
27. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
Fontana RJ; Goodman ZD; Dienstag JL; Bonkovsky HL; Naishadham D; Sterling RK; Su GL; Ghosh M; Wright EC;
Hepatology; 2008 Mar; 47(3):789-98. PubMed ID: 18175357
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of platelet derived growth factor-BB, transforming growth factor-beta1, matrix metalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis.
Zhang BB; Cai WM; Weng HL; Hu ZR; Lu J; Zheng M; Liu RH
World J Gastroenterol; 2003 Nov; 9(11):2490-6. PubMed ID: 14606082
[TBL] [Abstract][Full Text] [Related]
29. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
Yilmaz S; Bayan K; Tüzün Y; Dursun M; Kaplan A; Ozmen S; Canoruç F; Akkuş Z
Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
[TBL] [Abstract][Full Text] [Related]
30. Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease.
Pereira TN; Lewindon PJ; Smith JL; Murphy TL; Lincoln DJ; Shepherd RW; Ramm GA
J Hepatol; 2004 Oct; 41(4):576-83. PubMed ID: 15464237
[TBL] [Abstract][Full Text] [Related]
31. [Liver histological changes in chronic hepatitis B patients with elevated ALT less than 2 x ULN].
Xian JC; Xu HT; He YL; Shen ML; Chen YB; Zhang LX; Xiao L; Li Y; Han LB; Li H; Lu LG
Zhonghua Gan Zang Bing Za Zhi; 2011 Jun; 19(6):431-5. PubMed ID: 22053373
[TBL] [Abstract][Full Text] [Related]
32. Can serum markers be used to reliably detect liver fibrosis?
Afdhal N
Nat Clin Pract Gastroenterol Hepatol; 2005 Mar; 2(3):132-3. PubMed ID: 16265151
[No Abstract] [Full Text] [Related]
33. Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease.
Miele L; Forgione A; La Torre G; Vero V; Cefalo C; Racco S; Vellone VG; Vecchio FM; Gasbarrini G; Rapaccini GL; Neuman MG; Grieco A
Transl Res; 2009 Oct; 154(4):194-201. PubMed ID: 19766963
[TBL] [Abstract][Full Text] [Related]
34. [Noninvasive evaluation of liver fibrosis in chronic hepatitis B patients].
Chen Y; Wang BE; Jia JD; Qian LX; Wang TL; Chen MH; Chen GY; He W; Ding HG; Yin SS; Zhang Y; Dong Z
Zhonghua Gan Zang Bing Za Zhi; 2003 Jun; 11(6):354-7. PubMed ID: 12837216
[TBL] [Abstract][Full Text] [Related]
35. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
Kim SM; Sohn JH; Kim TY; Roh YW; Eun CS; Jeon YC; Han DS; Oh YH
Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
[TBL] [Abstract][Full Text] [Related]
36. Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1--possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis.
Flisiak R; Maxwell P; Prokopowicz D; Timms PM; Panasiuk A
Hepatogastroenterology; 2002; 49(47):1369-72. PubMed ID: 12239944
[TBL] [Abstract][Full Text] [Related]
37. [Correlation of the expression of NF-κB p65 and hepatic fibrosis in hepatitis patients].
Li WW; Wang QC; Song XW; Shen BS; Geng XL; Hou LJ
Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(27):1886-8. PubMed ID: 23134958
[TBL] [Abstract][Full Text] [Related]
38. Serum liver fibrosis markers discriminate significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase.
Liao Y; Gong J; Zhou W; Dong H; Liang J; Luo M; Hu B
J Med Virol; 2019 Apr; 91(4):642-649. PubMed ID: 30537157
[TBL] [Abstract][Full Text] [Related]
39. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
[TBL] [Abstract][Full Text] [Related]
40. A practical scoring system for predicting cirrhosis in patients with chronic viral hepatitis.
Cheong JY; Um SH; Seo YS; Shin SS; Park RW; Kim DJ; Hwang SG; Lee YJ; Cho M; Yang JM; Kim YB; Park YN; Cho SW
Hepatogastroenterology; 2012; 59(120):2592-7. PubMed ID: 23178625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
